ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Þorvaldsdóttir, Richard Rosenquist, Manja Meggendorfer et al.|Leukemia|2025Cited by 5
Severe COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia or Indolent B-Cell Non-Hodgkin Lymphoma Who Received Pre-Exposure Prophylaxis with Tixagevimab and Cilgavimab in Italy: Preliminary Results of the Observational Study By the Gimema Working Party on Chronic Lymphoproliferative Disorders and By the Fondazione Italiana LinfomiGian Matteo Rigolin, Antonio Cuneo, Antonio Urso et al.|Blood|2024Cited by 0